Relation of coronary microvascular dysfunction in hypertrophic cardiomyopathy to contractile dysfunction independent from myocardial injury

American Journal of Cardiology

Volumn 107, Issue 10, 2011, Pages 1522-1528

  Timmer, Stefan A J ^a   Germans, Tjeerd ^a   Gtte, Marco J W ^a   Rssel, Iris K ^a   Lubberink, Mark ^a   Ten Berg, Jurrien M ^b   Ten Cate, Folkert J ^c   Lammertsma, Adriaan A ^a   Knaapen, Paul ^a   Van Rossum, Albert C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; DILTIAZEM; METOPROLOL; VERAPAMIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY MICROVASCULAR DYSFUNCTION; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART MUSCLE PERFUSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MICROANGIOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

CARDIOMYOPATHY, HYPERTROPHIC; CARDIOVASCULAR SYSTEM; CORONARY CIRCULATION; CORONARY VESSELS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS; MIDDLE AGED; MYOCARDIAL CONTRACTION; POSITRON-EMISSION TOMOGRAPHY;

EID: 79955630030     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.01.029     Document Type: Article

References (34)

1. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320 (Pubitemid 34250486)
2. P. Camici, G. Chiriatti, R. Lorenzoni, R.C. Bellina, R. Gistri, G. Italiani, O. Parodi, P.A. Salvadori, N. Nista, and L. Papi Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography J Am Coll Cardiol 17 1991 879 886
3. R. Lorenzoni, R. Gistri, F. Cecchi, I. Olivotto, G. Chiriatti, P. Elliott, W.J. McKenna, and P.G. Camici Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction Am Heart J 136 1998 972 981 (Pubitemid 29080854)
4. I. Olivotto, F. Cecchi, R. Gistri, R. Lorenzoni, G. Chiriatti, F. Girolami, F. Torricelli, and P.G. Camici Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy J Am Coll Cardiol 47 2006 1043 1048
5. S.E. Petersen, M. Jerosch-Herold, L.E. Hudsmith, M.D. Robson, J.M. Francis, H.A. Doll, J.B. Selvanayagam, S. Neubauer, and H. Watkins Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging Circulation 115 2007 2418 2425 (Pubitemid 46717964)
6. O.I. Soliman, M.L. Geleijnse, M. Michels, P.A. Dijkmans, A. Nemes, B.M. Van Dalen, W.B. Vletter, P.W. Serruys, and F.J. ten Cate Effect of successful alcohol septal ablation on microvascular function in patients with obstructive hypertrophic cardiomyopathy Am J Cardiol 101 2008 1321 1327
7. B. Sotgia, R. Sciagra, I. Olivotto, G. Casolo, L. Rega, I. Betti, A. Pupi, P.G. Camici, and F. Cecchi Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy J Nucl Med 49 2008 1090 1096 (Pubitemid 351948017)
8. F. Cecchi, I. Olivotto, R. Gistri, R. Lorenzoni, G. Chiriatti, and P.G. Camici Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy N Engl J Med 349 2003 1027 1035 (Pubitemid 37087617)
9. M.S. Maron, I. Olivotto, B.J. Maron, S.K. Prasad, F. Cecchi, J.E. Udelson, and P.G. Camici The case for myocardial ischemia in hypertrophic cardiomyopathy J Am Coll Cardiol 54 2009 866 875
10. P. Knaapen, R. Boellaard, M.J. Gtte, P.A. Dijkmans, L.M. van Campen, C.C. de Cock, G. Luurtsema, C.A. Visser, A.A. Lammertsma, and F.C. Visser Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy J Nucl Med 45 2004 1299 1304 (Pubitemid 47618526)
11. L. Choudhury, H. Mahrholdt, A. Wagner, K.M. Choi, M.D. Elliott, F.J. Klocke, R.O. Bonow, R.M. Judd, and R.J. Kim Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy J Am Coll Cardiol 40 2002 2156 2164 (Pubitemid 36005903)
12. S.J. Dong, J.H. MacGregor, A.P. Crawley, E. McVeigh, I. Belenkie, E.R. Smith, J.V. Tyberg, and R. Beyar Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy A three-dimensional tagged magnetic resonance imaging study Circulation 90 1994 1200 1209 (Pubitemid 24284441)
13. P. Knaapen, T. Germans, P.G. Camici, O.E. Rimoldi, F.J. ten Cate, J.M. ten Berg, P.A. Dijkmans, R. Boellaard, W.G. van Dockum, M.J. Gotte, J.W. Twisk, A.C. van Rossum, A.A. Lammertsma, and F.C. Visser Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy Am J Physiol Heart Circ Physiol 294 2008 H986 H993
14. T. Germans, M.J. Gtte, R. Nijveldt, M.D. Spreeuwenberg, A.M. Beek, J.G. Bronzwaer, C.A. Visser, W.J. Paulus, and A.C. van Rossum Effects of aging on left atrioventricular coupling and left ventricular filling assessed using cardiac magnetic resonance imaging in healthy subjects Am J Cardiol 100 2007 122 127 (Pubitemid 46961906)
15. J.T. Marcus, M.J. Gtte, L.K. DeWaal, M.R. Stam, R.J. Van der Geest, R.M. Heethaar, and A.C. Van Rossum The influence of through-plane motion on left ventricular volumes measured by magnetic resonance imaging: implications for image acquisition and analysis J Cardiovasc Magn Reson 1 1999 1 6
16. M.J. Gtte, T. Germans, I.K. Rssel, J.J. Zwanenburg, J.T. Marcus, A.C. van Rossum, and D.J. van Veldhuisen Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function J Am Coll Cardiol 48 2006 2002 2011 (Pubitemid 44738446)
17. P. Knaapen, M.J. Gtte, W.J. Paulus, J.J. Zwanenburg, P.A. Dijkmans, R. Boellaard, J.T. Marcus, J.W. Twisk, C.A. Visser, A.C. van Rossum, A.A. Lammertsma, and F.C. Visser Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study Radiology 240 2006 380 388 (Pubitemid 44098633)
18. H. Iida, I. Kanno, A. Takahashi, S. Miura, M. Murakami, K. Takahashi, Y. Ono, F. Shishido, A. Inugami, and N. Tomura Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography Strategy for quantification in relation to the partial-volume effect Circulation 78 1988 104 115
19. F. Hermansen, S.D. Rosen, F. Fath-Ordoubadi, J.S. Kooner, J.C. Clark, P.G. Camici, and A.A. Lammertsma Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols Eur J Nucl Med 25 1998 751 759 (Pubitemid 28377039)
20. P. Knaapen, P.G. Camici, K.M. Marques, R. Nijveldt, J.J. Bax, N. Westerhof, M.J. Gtte, M. Jerosch-Herold, H.R. Schelbert, A.A. Lammertsma, and A.C. van Rossum Coronary microvascular resistance: methods for its quantification in humans Basic Res Cardiol 104 2009 485 498
21. A. Gimelli, J. Schneider-Eicke, D. Neglia, G. Sambuceti, A. Giorgetti, G. Bigalli, G. Parodi, R. Pedrinelli, and O. Parodi Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy J Am Coll Cardiol 31 1998 366 373 (Pubitemid 28153457)
22. K. Rajappan, O.E. Rimoldi, P.G. Camici, N.G. Bellenger, D.J. Pennell, and D.J. Sheridan Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis Circulation 107 2003 3170 3175 (Pubitemid 36793087)
23. B.J. Maron, J.K. Wolfson, S.E. Epstein, and W.C. Roberts Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy J Am Coll Cardiol 8 1986 545 557 (Pubitemid 16048006)
24. O.I. Soliman, P. Knaapen, M.L. Geleijnse, P.A. Dijkmans, A.M. Anwar, A. Nemes, M. Michels, W.B. Vletter, A.A. Lammertsma, and F.J. ten Cate Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography Heart 93 2007 1204 1212 (Pubitemid 47492903)
25. P. Knaapen, W.G. van Dockum, M.J. Gtte, K.A. Broeze, J.P. Kuijer, J.J. Zwanenburg, J.T. Marcus, W.E. Kok, A.C. van Rossum, A.A. Lammertsma, and F.C. Visser Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study J Nucl Cardiol 13 2006 660 667 (Pubitemid 44283785)
26. C.M. Kramer, N. Reichek, V.A. Ferrari, T. Theobald, J. Dawson, and L. Axel Regional heterogeneity of function in hypertrophic cardiomyopathy Circulation 90 1994 186 194 (Pubitemid 24203679)
27. A.M. Varnava, P.M. Elliott, S. Sharma, W.J. McKenna, and M.J. Davies Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease Heart 84 2000 476 482
28. P. Knaapen, W.G. van Dockum, O. Bondarenko, W.E. Kok, M.J. Gtte, R. Boellaard, A.M. Beek, C.A. Visser, A.C. van Rossum, A.A. Lammertsma, and F.C. Visser Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET J Nucl Med 46 2005 923 929 (Pubitemid 43733505)
29. P. Melacini, F. Corbetti, C. Calore, V. Pescatore, G. Smaniotto, A. Pavei, F. Bobbo, L. Cacciavillani, and S. Iliceto Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy Int J Cardiol 128 2008 364 373
30. K.M. Harris, P. Spirito, M.S. Maron, A.G. Zenovich, F. Formisano, J.R. Lesser, S. Mackey-Bojack, W.J. Manning, J.E. Udelson, and B.J. Maron Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 114 2006 216 225 (Pubitemid 44297115)
31. Z.B. Popovi, D.H. Kwon, M. Mishra, A. Buakhamsri, N.L. Greenberg, M. Thamilarasan, S.D. Flamm, J.D. Thomas, H.M. Lever, and M.Y. Desai Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging J Am Soc Echocardiogr 21 2008 1299 1305
32. D.S. Thompson, N. Naqvi, S.M. Juul, R.H. Swanton, D.J. Coltart, B.S. Jenkins, and M.M. Webb-Peploe Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy Br Heart J 44 1980 488 498 (Pubitemid 11217129)
33. L. Choudhury, P. Elliott, O. Rimoldi, M. Ryan, A.A. Lammertsma, H. Boyd, W.J. McKenna, and P.G. Camici Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment Basic Res Cardiol 94 1999 49 59 (Pubitemid 29103612)
34. C.J. Jensen, M. Jochims, P. Hunold, M. Forsting, J. Barkhausen, G.V. Sabin, O. Bruder, and T. Schlosser Assessment of left ventricular function and mass in dual-source computed tomography coronary angiography: influence of beta-blockers on left ventricular function: Comparison to magnetic resonance imaging Eur J Radiol 74 2010 484 491